ATTD Diabetes Talks: Insulin in Practice
Basal insulin remains one of the most powerful, and often misunderstood, tools in the management of Type 2 diabetes.
In Insulin in Practice, a new series from ATTD Diabetes Talk, we take a clear, practical look at how and when basal insulin should be used in today’s clinical landscape. Hosted by Robert Gabbay MD, PhD, this series goes beyond theory to explore the real-world principles of Basal Insulin Therapy, combining physiology, pharmacology, and guideline-based recommendations with clinical insight you can apply immediately.
Episodes Line-Up:
- Principles of Basal Insulin Therapy in T2D
- Identifying Patients for Insulin Initiation in T2D
- Safe and Effective Insulin Titration Strategies
- Fixed-Ratio Combinations (FRCs) in Practice
- Smart Tools & Technology for Better Insulin Outcomes
- Preventing & Managing Hypoglycemia
- Overcoming Barriers to Insulin Adherence
- Personalized Approaches for Complex Populations
Meet Your Host
Robert Gabbay MD, PhD
Diabetes healthcare executive and former CMO of Joslin at Harvard, known for leading innovation in diabetes research, care, and prevention. A strategic, collaborative leader driving population health impact through chronic care models, digital health, and primary care transformation, with national and international recognition and a strong publication and media presence.
🎙️ Episode 1: Principles of Basal Insulin Therapy in Type 2 Diabetes
Special Guest: Dr. Giulio Romeo
In the first episode of the series, we discuss the role of basal insulin in normal physiology and why it matters in Type 2 diabetes, current guidelines and recommendations for basal insulin therapy, alternatives to basal insulin therapy and more.
Subscribe today and be the first to access expert insights when episodes go live!
This series is supported by an independent medical educational grant from Sanofi.